510(k) Report

510(k) · Cleared

Cleared

Trimotion Injector

K102999510(k) TraditionalCleared Dec 29, 2011447-day reviewClass I21 CFR 886.4300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Kaneka Corp. · OTZ Graft Insertion Instrument For Endothelial Keratoplasty

Cleared on Dec 29, 2011 as substantially equivalent to K090626 (Ocular Systems, Inc., 2011) after a 447-day review. Its family tree reaches back 1 generation to 2011.

Decided
Dec 29, 2011
Review
447 days
Class
Class I
Product code
OTZ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K090626 (2011). No later device cites it as a predicate yet.

K090626 · Endoserter · Ocular Systems, Inc. · 201120102012
K090626 · Endoserter · Ocular Systems, Inc. · 20110
  1. Root · 1 generation backK090626 EndoserterOcular Systems, Inc. · 2011
  2. This deviceK102999 Trimotion InjectorKaneka Corp. · 2011
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K090626EndoserterOcular Systems, Inc.2011—
0 (this device)K102999Trimotion InjectorKaneka Corp.2011—
FIG. 1 — Lineage of K102999, 2011–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OTZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OTZ device

  1. #1 K203586 EndoSerter-PLscore 3.1 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K090626Endoserter
Cleared while this submission was under review
Summary page 1
…Class I reserved Predicate Device: The predicate device is the Ocular System Inc. EndoSerterTm corneal endotheliumn delivery instrument (510(k) No. K090626), cleared by the Food and Drug Administration on January 21, 2011. Device Description: The Kaneka TrimotionTM Injector is indic…
Ocular Systems, Inc.2011—

Also cleared against K090626: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K090626.

How does its category compare?

All OTZ devices

OTZ Graft Insertion Instrument For Endothelial Keratoplasty: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · OTZ

1in 2022

2011: 22012: 22022: 1
2007high 2 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OTZ

Too few OTZ 510(k)s in any year since 2007 to give a median.

Recalls per year · OTZ

No recall names OTZ since 2007.

Adverse event reports per year · OTZ

1in 2024

2024: 1
2007high 1 (2024) · low 0 (2007)2025

MAUDE reports naming product code OTZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20112—00
20122—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20221—00
20230—00
20240—01
20250—00
20260—0—

What is it indicated for?

The Kaneka TrimotionTM Injector is indicated for insertion and placement of donor corneal tissue (diameter: < 8.5 mm; thickness: 0.115-0.200 mm) into the anterior chamber of the recipient eye through a minimum 5.5 mm incision during a Descemet's Stripping with Automated Endothelial Keratoplasty (DSAEK) procedure.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K102999: Trimotion Injector.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K102999

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026